Cite
Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in HDV RNA.
MLA
Deterding, Katja, et al. “Bile Acid Increase during Bulevirtide Treatment of Hepatitis D Is Not Associated with a Decline in HDV RNA.” Journal of Viral Hepatitis, vol. 30, no. 7, July 2023, pp. 597–606. EBSCOhost, https://doi.org/10.1111/jvh.13831.
APA
Deterding, K., Xu, C., Port, K., Dietz, F. C., Xun, J., Maasoumy, B., Cornberg, M., & Wedemeyer, H. (2023). Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in HDV RNA. Journal of Viral Hepatitis, 30(7), 597–606. https://doi.org/10.1111/jvh.13831
Chicago
Deterding, Katja, Chengjian Xu, Kerstin Port, Fricke, Christopher Dietz, Jiang Xun, Benjamin Maasoumy, Markus Cornberg, and Heiner Wedemeyer. 2023. “Bile Acid Increase during Bulevirtide Treatment of Hepatitis D Is Not Associated with a Decline in HDV RNA.” Journal of Viral Hepatitis 30 (7): 597–606. doi:10.1111/jvh.13831.